Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ana AslanfiledCriticalAna Aslan
Priority to RO127498ApriorityCriticalpatent/RO95374B1/en
Publication of RO95374A2publicationCriticalpatent/RO95374A2/en
Publication of RO95374B1publicationCriticalpatent/RO95374B1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicinal Preparation
(AREA)
Indole Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Inventia se refera la un medicament antidepresiv constituit din asocierea L- triptofanului cu clorhidratul de procaina, raportul de asociere a celor doua componente putînd varia între 0,2 si 3, iar conditionarea lor facîndu-se sub forma de fiole, comprimate sau capsule operculate, utilizînd adjuvanti în sine cunoscuti.The invention relates to an antidepressant drug comprising the association of L-tryptophan with procaine hydrochloride, the association ratio of the two components being between 0.2 and 3, and their conditioning being in the form of ampoules, tablets or capsules, using adjuvants known per se.
Pharmaceutical compositions containing an antidepressant of the structural type of 10,11-dihydrodibenzo(b,f)azepine,a dibenzo-(a,d)(1,4)cycloheptadiene and/or a 10,11-dihydro-benzo-(b,f)oxepine and a pyrolidinone derivative